Targeting the MAPK Signaling Pathway in Cancer: Promising Preclinical Activity with the Novel Selective ERK1/2 Inhibitor BVD-523 (Ulixertinib)
U. Germann, Brinley F Furey, W. Markland, R. R. Hoover +17 more
Researcher profile · Semantic Scholar
U. Germann, Brinley F Furey, W. Markland, R. R. Hoover +17 more
Amy B. Hall, D. Newsome, Yuxin Wang, D. Boucher +16 more
F. Foijer, L. Albacker, B. Bakker, D. Spierings +11 more
R. Winquist, D. Boucher, M. Wood, Brinley F Furey
Tiansheng Wang, J. Duffy, Jian Wang, S. Halas +19 more
R. Winquist, Brinley F Furey, D. Boucher
Brandon Zimmerman, Leslie Dakin, Anne Fortier, Evanthia Nanou +30 more
Jon H Come, Timothy J Senter, Michael P Clark, John J. Court +40 more
R. Winquist, Amy B. Hall, Brenda K. Eustace, Brinley F Furey
D. Boucher, R. R. Hoover, Yuxin Wang, Yong Gu +15 more
J. Jain, Jianguo Ma, Brinley F Furey, C. Récher +13 more
James J. Fink, Nathaniel Delaney-Busch, Ryan Dawes, Evanthia Nanou +17 more
C. Buser, Brinley F Furey, R. R. Hoover, M. Harding +1 more
S. Galvani, Kelly E. Sullivan, Heather Weber, Michael Parsons +7 more
Angelo Blasio, Gizelle Mccarthy, Shyamesh Kumar, K. Stavropoulos +5 more
Angelo Blasio, Kelly E. Sullivan, James J. Mann, Guan-Yu Wang +15 more
F. Foijer, L. Albacker, B. Bakker, D. Spierings +11 more
Howard Li, I. Kadiyala, M. Briggs, R. Shawgo +7 more
J. Pollard, P. Reaper, Julie Jones, C. S. Barnes +23 more
Brinley F Furey, Jianguo Ma, Guizhi Yang, Jianbo Zhang +2 more